Amrutanjan Health Care Limited

rs,

t ¿ BSE Limited ó.p.t,t.n, of CorPorate Services 1tt Floor, P.J. Towers, Dalal Street' Mumbai400 001 ScriP Code: 590006 ffre Uationat Stock Exchange of lndia Limited ii*.f

23.95%

FY22 (Rs. in Crores) Gross Sales 455.85 Profit Before Tax 367.78 90.58 FY22 FY21 Growth: 23.95% Gross Sales - E Comm. 9.55 4.43 81.90 FY22 FY21 Growth: 10.60% Profit After Tax 67.19

10.60%

0.58 FY22 FY21 Growth: 23.95% Gross Sales - E Comm. 9.55 4.43 81.90 FY22 FY21 Growth: 10.60% Profit After Tax 67.19 61.19 FY22 FY21 FY22 FY21 Growth: 115.58% Growth: 9.81% Investor

115.58%

.90 FY22 FY21 Growth: 10.60% Profit After Tax 67.19 61.19 FY22 FY21 FY22 FY21 Growth: 115.58% Growth: 9.81% Investor Presentation | Quarter and Year Ended 31st March 2022 6 Financials – FY2

9.81%

Growth: 10.60% Profit After Tax 67.19 61.19 FY22 FY21 FY22 FY21 Growth: 115.58% Growth: 9.81% Investor Presentation | Quarter and Year Ended 31st March 2022 6 Financials – FY22 (Rs. in Crore

15.66%

Financials – FY22 (Rs. in Crores) Employee Benefit Expenses 48.23 41.70 FY22 FY21 Increase: 15.66% Advertisement & Selling Expenses Other Expenses 55.03 45.99 42.64 30.21 FY22 FY21 FY22

19.66%

Selling Expenses Other Expenses 55.03 45.99 42.64 30.21 FY22 FY21 FY22 FY21 Increase: 19.66% Increase: 41.15% Investor Presentation | Quarter and Year Ended 31st March 2022 7 Financials –

41.15%

Other Expenses 55.03 45.99 42.64 30.21 FY22 FY21 FY22 FY21 Increase: 19.66% Increase: 41.15% Investor Presentation | Quarter and Year Ended 31st March 2022 7 Financials – FY22 – OTC Divisio

20.18%

als – FY22 – OTC Division (Rs. in Crores) Gross Sales - OTC 416.73 346.75 FY22 FY21 Growth: 20.18% Gross Sales - Comfy 69.50 54.36 FY22 FY21 Growth: 27.85% Notes: • Key raw material - Ment

27.85%

.73 346.75 FY22 FY21 Growth: 20.18% Gross Sales - Comfy 69.50 54.36 FY22 FY21 Growth: 27.85% Notes: • Key raw material - Menthol Crystal price is lower when compared to FY21. • The prices

Rs.38.53

prices of packing materials are higher when compared to FY21. • Advertisement spend for FY22 is Rs.38.53 cr against Rs.26.52 cr for FY21. Advertisement spend for Comfy has increased from Rs.9.77 cr for F

Rs.26.52

aterials are higher when compared to FY21. • Advertisement spend for FY22 is Rs.38.53 cr against Rs.26.52 cr for FY21. Advertisement spend for Comfy has increased from Rs.9.77 cr for FY21 to Rs.17.43 cr f

Notes

2

Ref

1

We remain focused on executing our key priorities

1

Ref

Pursuant to Regulation 30 read wìth Para.A :li:lÏ: ;i."J";";;;;"ts) and Year ended 31't March 2022' Regulations' 20r 5 we herebv schedule lll of the SEBI (Listing O:lig:tions ::1 enclose the lnvestor Presentation for the quarter KindlY take the same on record' Thanking You, Yours faithfullY, For Amrutanjan Health Care Limited (M Srinivasan) #;;;;;cretary & comPliance officer Encl: As above Anrrutanian Health Care Limited Churr,h Road, 004 103, (Ctld No. 4?-45), Luz MylaDore, chennai - ó00 T¿nlil Nadu, lrrdia. Ti,l :+91-44 - 2499 44ó\ r û I .i.{ l4óó 9(r0r, F,rx:+91-.f.1 - 2499 4585 E-r r r¡ iI : custonì('rcar-e(!anrrut:rrr.jarr.cont Wt i; Sitt :wwv/. ånrr-r¡tàrrian.(onì Te¡ll Free No.: I - 800 - 4?5 - .1545 ctN - 124231 1 N1936P1C000017 Amrutanjan Health Care Limited Investor Presentation - Quarter & Year Ended 31st March 2022 Date: 24th May 2022 Contents a. Business Update b. FY22 Performance c. Q4 FY22 Performance d. Way Forward Investor Presentation | Quarter and Year Ended 31st Mar

Notes

• Key raw material - Menthol Crystal price is lower when compared to FY21. • The prices of packing materials are higher when compared to FY21. • Advertisement spend for FY22 is Rs.38.53 cr against Rs.26.52 cr for FY21. Advertisement spend for Comfy has increased from Rs.9.77 cr for FY21 to Rs.17.43 cr for FY22. Investor Presentation | Quarter and Year Ended 31st March 2022 8 Financials – FY22 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 37.34 19.51 FY22 FY21 Growth: 91.39% Gross Sales - Electro Plus 30.26 12.82 FY22 FY21 Growth: 136.04%

Notes

• Gross Margin has improved by 1,131 basis points when compared to FY21 mainly due to product mix. • Advertisement spend is at 5.57 cr for FY22 against 3.10 cr for FY21. • Business is continuing to be healthier with complete cash collected for Fruitnik. Investor Presentation | Quarter and Year Ended 31st March 2022 9 Key Financial Ratios Return on Capital Employed % Operating Profit Margin (%) 37.09% 33.43% 24.76% 25.00% 24.50% 24.00% 23.50% 23.00% 22.50% 22.00% 21.50% 21.00% 22.44% FY22 FY21 FY22 FY21 Debtors Turnover Ratio Inventory Turnover Ratio 15.09 14.52 18.68 16.17 19.00 18.50 18.00 17.50 17.00 16.50 16.00 15.50 15.00 14.50 FY22 FY21 FY22 FY21 38.00% 37.00% 36.00% 35.00% 34.00% 33.00% 32.00% 31.00% 16.00 15.75 15.50 15.25 15.00 14.75 14.50 14.25 14.00 Investor Presentation | Quarter and Year Ended 31st March 2022 10 Q4 FY22 Performance Investor Presentation | Quarter and Year Ended 31st March 2022 11 Financials – Q4 FY22 (Rs. in Crores) Gross Sales 124.37 Profit Before Tax Prof

We remain focused on executing our key priorities

• Expand distribution • Go global • Go digital • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter and Year Ended 31st March 2022 15 Investor Presentation | Quarter and Year Ended 31st March 2022 16